Alamar Biosciences, Inc. Common Stock (ALMR) on Friday announced the pricing of its upsized initial public offering of 11.25 million shares of stock at $17 per share.
The offering is expected to raise gross proceeds of approximately $191.3 million, before underwriting discounts and expenses.
The company has granted underwriters a 30-day option to purchase up to an additional 1.69 million shares at the offering price.
The option could increase total proceeds if exercised.
The shares are expected to begin trading on the Nasdaq Global Select Market on April 17, under the ticker symbol "ALMR," with the offering anticipated to close on April 20.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.